CYCLOCYTIDINE

Cytarabine is a pyrimidine analogue inhibiting DNA synthesis, used in leukemia treatment. Side effects include myelosuppression, nausea, fever, and mucositis. Only GMP materials will be supplied, logistics all according to GDP.

SKU: c8608e53964c Category: Tag:

Product Description


Mechanism of Action

Cyclocytidine is a cytidine analogue that is metabolized into cytarabine (AraC) in vivo. It inhibits DNA polymerase, incorporates into DNA and halts chain elongation, leading to apoptosis in rapidly dividing cells. Its cyclic structure provides improved stability and pharmacokinetic characteristics.

Benefits and Advantages

Used in nucleosideanalogue research, leukemiamodel studies, DNApolymerase inhibition assays, and prodrugactivation pathway modelling.

Side Effects and Risks

Risks include bonemarrow suppression, hepatotoxicity, mucositis, neurotoxicity and immunosuppression. Handle with cytotoxicdrug containment.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C9H14N3O5

Molecular Weight

225.20 g/mol

CAS Number

31698-14-3

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

H2O 200 ( mg/mL)

Purity

Purity information is available upon request (COA).

Synonym

ANCITABINE; Cyclocytidine; 31698-14-3; 2,2'-Cyclocytidine; Ancitabina

IUPAC/Chemical Name

(2R,4R,5R,6S)-4-(hydroxymethyl)-10-imino-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-5-ol

InChl Key

BBDAGFIXKZCXAH-CCXZUQQUSA-N

InChl Code

InChI=1S/C9H11N3O4/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8/h1-2,4,6-8,10,13-14H,3H2/t4-,6-,7+,8-/m1/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/25051;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download